Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases
Gregory C. Fox(Washington University in St. Louis), Katherine N. Weilbaecher(Washington University in St. Louis)
Cited by 22
Related Papers
Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
|Journal of Clinical Investigation|2021|111
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
|Journal of Clinical Investigation|2012|102
Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment
|Cancer Research|2011|78
Interferon-γ Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases
|Journal of Biological Chemistry|2008|45
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
|JCI Insight|2019|21